Antibodies against FGF2 and FGF8 have also shown promising results in inhibiting tumour progression and angiogenesis [236,237] A human single-chain variable fragment (ScFvs; 1A2) that binds to human FGF2 was identified via screening of a human scFv phage library [238]. Here, FGF2 is linked to neoplasm.